Cancer imaging is a growing field with screening programs for secondary prevention through early detection and advances in therapeutics as key drivers. Since primary prevention strategies are lacking for many types of cancers, imaging has a pivotal role in early detection, diagnosis and treatment response evaluation. Our research group has a long-standing experience especially in mammography screening for breast cancer with early pioneer trials in the 1970 and 80’s, clinical and epidemiological studies and recently a large population-based screening trial investigating 3D mammography (breast tomosynthesis) as a screening tool (The Malmö Breast Tomosynthesis Screening Trial, MBTST). The current scope of our research group embraces a wide spectrum of clinical cancer imaging research. Our field ranges from the epidemiological perspective, through clinical trials, and towards optimization and exploration of established and future imaging techniques. At present our main focus is in breast imaging, however we also run projects including other types of cancer such as prostate, colorectal cancer and metastatic disease including imaging modalities such as MRI and PET/CT. The research group is composed of a diversity of professions ensuring translational and interdisciplinary work. Radiologists, medical physicists, engineers and experts in statistics together form the core in the different projects. In addition, important collaborations are established in the fields of e.g. medical oncology, pathology, oncogenetics and health economy.